IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Immunocellular Therapeutics

CUSIP: 452536121 | 7 institutional holders

Quarters

Q3 2018Q2 2018Q1 2018Q4 2017Q3 2017
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2018

Citadel Advisors LLC14,139
0.0% of portfolio›$1
UBS Group AG1,995
0.0% of portfolio›$0
Proequities, Inc.0
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Citadel Advisors LLC
14,139$10.0%CoreVery HighMiami, FL2019-05-15
UBS Group AG
1,995$00.0%CoreMediumZurich, Switzerland2018-11-14
Proequities, Inc.
0$00.0%GrowthVery LowBirmingham, AL2018-11-13